Insys Therapeutics Inc.’s unsecured creditors want assurance that employees “involved or complicit” in criminal conduct will not receive severance pay as part of the pharmaceutical company’s Chapter 11, they told a Delaware bankruptcy court Tuesday.
A practicing surgeon who chairs the University of California San Diego’s gynecology department told a California judge on Tuesday that pelvic meshes made by Johnson & Johnson unit Ethicon have low rates of complications and that some of the problems could occur with any pelvic surgery, as the company begins its defense in the false-marketing trial.
Dueling experts disputed whether a Pittsburgh nursing home's lawyer improperly withheld documents from discovery during a negligence lawsuit and should be sanctioned, arguing the question before a Pennsylvania state court Tuesday.
A federal court in Puerto Rico threw out a jury verdict against a doctor for medical malpractice Tuesday, finding that the woman who filed suit after two allegedly botched back surgeries did not meet the statute of limitations for her claims.
The manager of a once-approved buyer of bankrupt Promise Healthcare's two remaining hospitals told a Delaware judge on Tuesday he was advised in blunt terms to walk away from his $23.5 million deal by the CEO of a company now awaiting approval to acquire both facilities for $22 million.
The government asked a Pennsylvania federal court on Tuesday to toss a whistleblower's lawsuit accusing a UnitedHealth Inc. unit of hospital billing fraud, claiming that the costs of discovery during the seven-year-long litigation don't justify keeping the suit alive.
The future of a Philadelphia children’s hospital was thrown into limbo Tuesday when a Delaware bankruptcy judge said he could not approve a $65 million post-petition loan as proposed, prompting the hospital’s operator to begin last-ditch efforts to reach a new deal with its lenders.
A New York federal judge has denied an attempt by six parents of disabled children to block a recent law repealing a religious exemption to mandatory vaccinations in New York schools, saying the state’s mandate doesn’t contravene federal disability law or the U.S. Constitution.
Zimmer Biomet is pressing the International Trade Commission to block German rival Heraeus Medical from bringing certain bone cement products into the United States, claiming its competitor is marketing those products using trade secrets obtained by pilfering Zimmer employees.
A Florida pharmaceutical company will pay a $200,000 civil penalty to the U.S. Securities and Exchange Commission to end allegations it leaked medical studies that bolstered its case for approval of a drug to market analysts before giving that information to investors.
A venture of MRK Partners has reportedly dropped $24 million on a Florida senior living facility, Taconic Investment Partners is said to be paying roughly $220 million for part of the former ABC campus in New York and Witkoff Group is said to have landed $31 million in financing for a residential project in California.
Aetna on Monday defeated a bid to include all of its policyholders in a putative class alleging it violated the Employee Retirement Income Security Act by denying plan participants coverage for medically necessary psychiatric treatment through a "hidden" exclusion.
Saudi Aramco has picked banks to assist on its planned $100 billion IPO, Cigna is looking to sell a group benefits insurance business that could be worth up to $6 billion, and a private equity firm is looking to usurp Mitel’s planned offer for California technology company Avaya.
A New Jersey state appeals court refused Tuesday to revive a wrongful termination suit by a self-described "whistleblower" attorney and nurse, finding that her documented history of performance issues at her medical staffing services job sunk her claim she was forced out of the role for complaining about noncompliance.
A Massachusetts hospital must face most of a lawsuit from a neurosurgeon claiming a former supervisor tried to derail her career by telling lies about her to another hospital, with a federal judge refusing to ax claims that she was discriminated against because she is a woman and Indian.
Two consumer groups have sued the U.S. Food and Drug Administration in California federal court, accusing the agency of shirking its responsibilities by failing to establish inspection programs mandated by the Food Safety Modernization Act.
A New Jersey town will get another chance to defend a buffer zone it placed around an abortion clinic following the Third Circuit’s decision Monday that more findings are needed to determine if the barrier violates the free speech of protesters.
Endo Pharmaceuticals Inc. on Tuesday announced it will pay $10 million and donate up to $1 million in prescription drugs to exit the lead bellwether cases in multidistrict opioid litigation.
Planned Parenthood opted Monday to exit Title X after nearly 50 years of participating in the federal grant program, rather than come into compliance with the Trump administration's so-called gag rule, which prohibits health care providers from giving patients abortion referrals.
The head of a proposed supervised injection site in Philadelphia pushed back against federal prosecutors Monday, insisting that the controversial facility, intended to reduce opioid overdose deaths, would not violate federal drug laws.
After five weeks of testimony, the state of California rested its main case Monday in the false-marketing trial against Johnson & Johnson and its Ethicon unit regarding a supposed failure to fully warn doctors and patients about the dangers of certain Ethicon surgical meshes.
Husch Blackwell has beefed up its Phoenix office with a four-attorney team specializing in complex commercial litigation that signed on from Lewis Roca.
The Utah Supreme Court tossed a suit accusing a University of Utah medical professor of botching a woman's surgery, saying the patient failed to meet the strict requirements laid out by the "deliberately stingy" Utah Governmental Immunity Act.
A teenager on Monday hit Juul and Philip Morris with a proposed class action in Illinois federal court alleging that deceptive marketing aimed at youths that downplayed the risk of nicotine addiction violates federal racketeering laws.
The Ohio federal judge supervising multidistrict opioid litigation approved lead attorneys Monday for a proposed “negotiation class” of local governments that would pursue nationwide settlements with drug companies accused of sparking a devastating addiction crisis.
In two recent disputes over whether hospitals serving a disproportionate number of low-income patients qualify for additional payments under Medicare and Medicaid, hospitals can claim one tentative win at the U.S. Supreme Court and one loss at the D.C. Circuit, say Stuart Gerson and Rob Wanerman of Epstein Becker.
The Superior Court of Delaware's recent decision in Conduent v. AIG Specialty Insurance adds to the authority that government investigations satisfy the "claim" and "wrongful act" definitions in claims-made professional liability insurance policies, and is instructive as to how policyholders can strengthen their coverage, say Donovan Hicks and Brian Scarbrough of Jenner & Block.
When crises occur, such as data security incidents or gender bias suits, a well-prepared law firm has a thoroughly tested communications plan at the ready, which ensures the firm is the most proactive news source, prevents the crisis from escalating and notifies stakeholders about mitigation efforts, says Zach Olsen at Infinite Global.
Website operators that collect and sell Nevada residents' personal information should lay the groundwork for compliance with Nevada Senate Bill 220, effective on Oct. 1, which will be the first U.S. law to grant consumers the right to opt out of the sale of their data, say attorneys at Morgan Lewis.
At attorney Greg Craig’s trial in D.C. federal court this week, the courtroom was cleared so prospective jurors could answer sensitive questions. Even seasoned litigators were left wondering about the nature of this subtle, yet significant, issue involving Sixth Amendment public trial rights, says Luke Cass at Quarles & Brady.
Recent months have seen a flurry of activity in Congress on prescription drug pricing and surprise medical bills, and additional developments are expected in September, including possible floor action, say attorneys at Akin Gump.
In the early 1980s, I was working on my Ph.D. in marine biology and ecology. As part of an international team of scientists studying oil spill impacts on marine ecosystems, I saw a niche opportunity to combine science and law, says Andrew Davis of Shipman & Goodwin.
Years of interviewing jurors and observing deliberation show that the amount juries award in damages is almost always influenced by the amount of the plaintiff's demand, but there are three ways defense counsel can combat this anchoring effect, says Christina Marinakis at Litigation Insights.
The D.C. federal court's recent decision in Athenex Pharma Solutions v. Azar gives the U.S. Food and Drug Administration a green light to review and exclude more substances from compounding under Section 503B of the federal Food, Drug and Cosmetic Act, say attorneys at Akin Gump.
The Third Circuit's ruling that nonvoting board observers did not carry the same fiduciary duties as actual board members in Obasi Investment v. Tibet Pharmaceuticals holds broad applicability for private equity, venture capital funds and other third parties that frequently designate board observers, say attorneys at White and Williams.
With emergency room visits involving care from out-of-network providers sometimes resulting in balance bills reaching thousands of dollars, 32 states this year have taken legislative action, and those that have not are under increasing pressure to do so, says Korey Clark of State Net Capitol Journal.
Recently, the U.S. Department of Health and Human Services' Office of Inspector General issued guidance on mandatory and voluntary self-disclosure actions for grant recipients. Grantees need to understand the risks and benefits offered by voluntary self-disclosure, considering the OIG's aggressive enforcement calendar, say attorneys at Ropes & Gray.
When litigating sexual assault cases that result in settlement, plaintiffs attorneys should thoroughly investigate how the plaintiff's medical bills were paid, and proactively prepare for insurers' potential health care liens, says Courtney Delaney of Epiq.
Although there continue to be corporate clients who are seduced by the idea that cheapest is always best when it comes to outside counsel, there are many negative implications on service delivery that result from myopically focusing only on cost reduction at the expense of quality and innovation, says Keith Maziarek at Katten Muchin.
The Eighth Circuit's recent decision in Lovelace v. Washington University School of Medicine — a suit alleging retaliation claims under the Family and Medical Leave Act and the Missouri Human Rights Act — reinforces for employers important causation principles and what constitutes a good-faith discrimination complaint, says Elisa Lintemuth at Dykema.